Two Sigma Investments
UBX

Two Sigma Investments’s Unity Biotechnology UBX Stock Holding History

Two Sigma Investments’s Portfolio UBX Stock Details UBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-21,500
Closed -$54.8K – 3228
2023
Q2 		$54.8K Buy
21,500
+1,900
+10% +$5.02K ﹤0.01% 2818
2023
Q1 		$31.9K Buy
+19,600
New +$78.5K ﹤0.01% 2808
2022
Q3 		– Sell
-4,109
Closed -$23K – 2836
2022
Q2 		$23K Sell
4,109
-9,401
-70% -$78.4K ﹤0.01% 2395
2022
Q1 		$151K Sell
13,510
-38,271
-74% -$429K ﹤0.01% 2377
2021
Q4 		$756K Buy
51,781
+25,359
+96% +$554K ﹤0.01% 2819
2021
Q3 		$793K Buy
26,422
+10,395
+65% +$367K ﹤0.01% 2836
2021
Q2 		$744K Buy
16,027
+3,903
+32% +$188K ﹤0.01% 2752
2021
Q1 		$727K Buy
+12,124
New +$827K ﹤0.01% 2602
2020
Q3 		– Sell
-1,144
Closed -$99K – 3573
2020
Q2 		$99K Buy
+1,144
New +$84.8K ﹤0.01% 2789
2020
Q1 		– Sell
-3,477
Closed -$251K – 3848
2019
Q4 		$251K Buy
+3,477
New +$245K ﹤0.01% 3306

Other funds holding UBX

AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
FFVM
Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Two Sigma Investments's UBX Position: Q3 2023 in Review

Two Sigma Investments sold out of Unity Biotechnology (UBX) in Q3 2023, closing a stake of 21,500 shares — an estimated $54.8K sold.

Two Sigma Investments first reported a position in UBX in Q4 2019 and held it in 10 quarters. The position peaked at $793K in Q3 2021. 36 funds tracked by Wall St. Rank hold UBX as of Q3 2023.

  • Two Sigma Investments reported no remaining Unity Biotechnology position as of Q3 2023 after selling out during the quarter.
  • Two Sigma Investments sold 21,500 Unity Biotechnology shares in Q3 2023, an estimated $54.8K.
  • Two Sigma Investments first reported a position in Unity Biotechnology in Q4 2019 and held it in 10 quarters.
  • Two Sigma Investments's Unity Biotechnology position peaked at $793K in Q3 2021.
  • 36 funds tracked by Wall St. Rank held Unity Biotechnology as of Q3 2023.

Based on Two Sigma Investments's 13F filing for Q3 2023, filed 14 Nov 2023.